Xtandi 40 MG capsule 120S

Ended Awarded Last action

Contract number
SPE2DR26FCJD3
Awardee
Awarding agency
Obligated
$13,266

Award facts

Contract value 100% obligated
$13,266.48 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $13,266.48 delivery order to DMS Pharmaceutical Group Inc. on May 1, 2026, for XTANDI 40 mg capsules (120-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business serving as the regional prime vendor under PPV-G GEN V, a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. Place of performance is Park Ridge, IL. The order carries a firm fixed-price structure with an ultimate completion date of May 4, 2026.

Quick answers

Who was awarded contract SPE2DR26FCJD3?

SPE2DR26FCJD3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 1, 2026.

How much is contract SPE2DR26FCJD3 worth?

The government has obligated $13,266 on SPE2DR26FCJD3.

Is contract SPE2DR26FCJD3 an order under another contract?

Yes. SPE2DR26FCJD3 is a delivery order under SPE2DR25D9113, an indefinite delivery contract.

Was contract SPE2DR26FCJD3 competed?

The extent of competition for SPE2DR26FCJD3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login